Login Join Premium
Top Canadian Stocks

Top Canadian Agriculture Stocks to Buy

Key takeaways

  • Agriculture is a long-term theme: Global population growth and food security concerns aren’t going away, and Canadian ag companies sit in a sweet spot given the country’s natural resource base and export infrastructure.
  • Diverse ways to play ag: This isn’t a one-trick sector. You can get exposure through fertilizer producers, crop input distributors, or equipment manufacturers, each with different growth drivers and margin profiles that let you tailor your portfolio to where you see the most value.
  • Commodity cycles will test your patience: Fertilizer and crop input prices can swing hard, and these stocks tend to follow. If you’re buying into this space, you need to be comfortable with earnings volatility and avoid chasing peaks when commodity prices are running hot.

3 stocks I like better than the ones on this list.

Canada’s agriculture sector is a strange one to invest in. The country is one of the world’s largest producers of potash, a critical fertilizer ingredient, yet the number of investable names on the TSX is surprisingly thin. You’ve got one dominant giant in Nutrien, and then a handful of junior companies at various stages of development. That concentration creates a real challenge for anyone trying to build meaningful exposure to Canadian fertilizer stocks.

Global food demand isn’t slowing down. Population growth, shrinking arable land, and the push for higher crop yields all point in the same direction: the world needs more fertilizer. Potash is a key piece of that equation, and Canada controls a massive share of global supply. That’s a structural advantage that doesn’t disappear in a recession.

The problem? Potash prices have been volatile. After spiking dramatically a few years ago, they’ve come back down significantly, and that’s weighed heavily on the sector. Nutrien’s stock has reflected that pain. Meanwhile, the junior names like Karnalyte Resources, Millennial Potash, and Gensource Potash are pre-revenue or early-stage, which means you’re making a very different kind of bet. One is a cash-flowing blue chip with a real dividend. The others are speculative plays on future production. Lumping them together as “agriculture stocks” doesn’t capture how different the risk profiles are.

I approached this list with that distinction front and center. If you’re looking for quality Canadian stocks with proven earnings, only one name here fits that description. The rest are more suited to investors with higher risk tolerance and a long time horizon, closer to what you’d find among Canadian small caps than established blue chips.

So what separates a legitimate early-stage potash play from a money pit? That’s the question I tried to answer for each name.

In This Article

  1. Nutrien Ltd. (NTR.TO)

Performance Summary

TickerYTD6M1Y3Y5YReport
NTR.TO+14.0%+1.9%+22.0%+6.8%+7.6%View Report

Returns shown are annualized price returns only and do not include dividends.

IMPORTANT: How These Stocks Are Selected+

The stocks featured in this article are selected from our proprietary grading system at Stocktrades Premium. Each stock in our database is scored across 9 core categories — Valuation, Profitability, Risk, Returns, Debt, Shareholder Friendliness, Outlook, Management, and Momentum. There are over 200 financial metrics taken into account when a stock is graded.

It is important to note that the grade the stocks are given below is a snapshot of the company's operations at this point in time. Financial conditions, earnings results, and market dynamics can shift quickly, especially in more volatile industries. A stock graded highly today may face headwinds tomorrow, and vice versa. We encourage readers to use these grades as a starting point for research.

Our grading system is updated regularly as new financial data becomes available. The stocks shown below and their rankings may change between visits as quarterly results, price movements, and other data points are incorporated.

Premium members have access to 6000+ stock reports with detailed breakdowns of each grading category, along with our stock screener, portfolio tracker, DCF calculator, earnings calendar, heatmap, and more.

Nutrien Ltd. (TSX: NTR)

Materials·Chemicals·CA
$97.49
Overall Grade5.7 / 10

Nutrien Ltd. is the world's largest provider of crop inputs and services, playing a critical role in global food production...

Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E16.3
P/B1.4
P/S1.3
P/FCF16.5
FCF Yield+6.1%
Growth & Outlook
Rev Growth (YoY)+3.5%
EPS Growth (YoY)-0.4%
Revenue 5yr+0.1%
EPS 5yr-3.4%
FCF 5yr-5.9%
Fundamentals
Market Cap$46.3B
Dividend Yield3.2%
Operating Margin+12.8%
ROE+9.6%
Interest Coverage5.2x
Competitive Edge
  • Nutrien's 1,700+ retail locations create a distribution moat that no pure-play fertilizer producer can replicate. This network generates sticky customer relationships and proprietary agronomic data, creating switching costs that go beyond commodity pricing.
  • As the world's largest potash producer controlling roughly 20% of global capacity, Nutrien has meaningful pricing influence. Saskatchewan's potash deposits are among the lowest-cost globally, providing structural cost advantages over competitors like K+S or ICL.
  • The vertical integration from mine to farm shelf eliminates intermediary margins and provides real-time demand visibility. When retail sees farmers pulling back on purchases, upstream production can adjust, a feedback loop competitors like Mosaic or CF Industries lack.
  • Global food security concerns and declining arable land per capita create a secular floor under fertilizer demand. Unlike energy, there is no viable substitute for potash, nitrogen, and phosphate in crop production.
By the Numbers
  • Total shareholder yield of 10.4% (2.9% dividend + 1.6% buyback + 5.2% debt paydown) is exceptional for a materials company, showing management is aggressively returning capital across all three channels simultaneously.
  • PEG ratio of 0.5 against a forward P/E of 10.8x suggests the market is pricing in commodity trough earnings while consensus expects 21% EPS growth to $5.65 next year. The gap between trailing (12.3x) and forward P/E (10.8x) confirms this disconnect.
  • Potash segment EBITDA margins expanded from 61.8% (FY2024) to 62.7% (FY2025) even as volumes grew 2.6%, indicating cost discipline and operating leverage on incremental tonnes rather than price-driven margin expansion alone.
  • FCF conversion trend scored a perfect 1.0 with FCF/NI at 0.91x, confirming high earnings quality. Capex-to-depreciation at 0.84x means the company is spending below replacement cost, which temporarily boosts FCF but also signals capital discipline.
  • All three upstream segments (potash, nitrogen, phosphate) simultaneously inflected from negative to positive revenue growth in FY2025 after two consecutive years of decline. Potash revenue surged 20.2% and nitrogen 11.8%, the first synchronized recovery since FY2022.
Risk Factors
  • Quick ratio of 0.53 is dangerously thin for a commodity business with seasonal working capital swings. Cash ratio of just 0.06x means only $772M cash against $13.2B net debt, leaving almost no liquidity buffer if fertilizer prices drop sharply.
  • Retail segment, which generates 65% of revenue, saw EBITDA decline 65.3% QoQ in the most recent quarter while revenue fell 56.9% QoQ. This seasonal pattern masks a deeper issue: retail crop tonnes sold have declined three consecutive years (13.4M to 11.9M).
  • Revenue growth 5Y CAGR is essentially flat at 0.09%, and consensus estimates project revenue declining from $27.6B (Y1) to $26.5B (Y3). This is a business with zero organic top-line growth outside of commodity price cycles.
  • Goodwill and intangibles represent 25.6% of total assets ($13.6B+), largely from the PotashCorp-Agrium merger. Tangible book value per share is only $23.44 versus $51.91 reported book, meaning the stock trades at 3.7x tangible book, not the 1.16x P/B that screens suggest.
  • Phosphate segment EBITDA margins compressed from 29.5% (FY2021) to 22.0% (FY2025) over four years, with absolute EBITDA falling from $540M to $382M. This segment is structurally deteriorating and now contributes just 6% of consolidated EBITDA.

This is a sector where honesty matters more than optimism. The fertilizer thesis is real. Canada’s potash reserves are world-class, and the long-term demand story for crop nutrients isn’t going away. But having a good thesis and having good investment options are two completely different things.

The gap between Nutrien and the rest of this list is enormous. It’s not a matter of degree. It’s a different category of investment entirely. And I think a lot of retail investors get burned in spaces like this because the macro story sounds so compelling that they overlook what they’re actually buying at the company level. A great commodity in the ground doesn’t help you if the company sitting on top of it can’t fund development, attract partners, or generate revenue within a reasonable timeframe.

If this sector interests you, be brutally clear with yourself about which type of bet you’re making. One pays you to wait. The others ask you to hope.

Written by Dan Kent

Dan Kent is the co-founder of Stocktrades.ca, one of Canada's largest self-directed investing platforms, serving over 1,800 Premium members and more than 1.4 million annual readers. He has been investing in Canadian and U.S. equities since 2009 and holds the Canadian Securities Course designation. Dan's investing approach is rooted in GARP — Growth at a Reasonable Price — focusing on companies with durable competitive advantages, strong fundamentals, and reasonable valuations. He publishes his real portfolio in full, logging every transaction and sharing the reasoning behind every move, a level of transparency rare in the Canadian investment research space. His work has been featured in the Globe and Mail, Forbes, Business Insider, CBC, and Yahoo Finance. He also co-hosts The Canadian Investor podcast, one of Canada's most listened-to investing podcasts. Dan believes that every Canadian investor deserves access to institutional-quality research without the institutional price tag — and that the best investing decisions come from data, discipline, and a community of people who are in it together.

View all posts →

Want More In-Depth Research?

Join Stocktrades Premium for exclusive stock analysis, model portfolios, and expert Q&A.

Start Your Free Trial